Directory

>

Srini Ramanathan

avatar

Srini Ramanathan

Chief Development Officer | Roivant Sciences

Menlo Park, California, United States

View contact details (it's free)

Srini Ramanathan

Summary

Srini Ramanathan is an accomplished Chief Development Officer at Roivant Sciences, where he oversees R&D operations and the establishment of new therapeutic ventures. With extensive experience in biopharmaceutics and drug development, he has played a pivotal role in the approval of numerous drugs across various therapeutic areas, including oncology and HIV. Prior to his current role, he held senior leadership positions at Horizon and Abbvie, focusing on clinical development and strategic guidance in immunology. Srini's career is marked by his ability to engage with regulatory agencies globally, ensuring successful drug approvals. He holds a Ph.D. in Pharmaceutics from Rutgers University and has a strong academic foundation in pharmacy. His leadership experience spans multiple organizations, contributing to his reputation as a key figure in the biopharmaceutical industry. Beyond his professional achievements, he is known for his collaborative approach and commitment to advancing innovative therapies.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Immigrant

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Srini Ramanathan

Work Experience

company logo

Chief Development Officer at

Roivant Sciences

May 2022 - Present

company logo

Senior Vice President at

Amgen, Inc.

May 2021 - May 2022

company logo

Group Vice President, Development Sciences, and Site Head at

Amgen, Inc.

January 2020 - April 2021

company logo

Vice President and Site Head at

Amgen, Inc.

April 2018 - January 2020

company logo

Senior Project Leader, Immunology Development at

AbbVie

August 2016 - March 2018

company logo

Senior Director, Head of Clinical Pharmacology at

Gilead Sciences Austria

April 2003 - August 2016

💼

Scientist, Pre-clinical Pharmacology at

ESSENTIAL THERAPEUTICS PRIVATE LIMITED

August 2001 - March 2003

💼

Scientist at

AFFYMAX LIMITED

March 2001 - August 2001

Logos provided by Logo.dev

Srini Ramanathan

Education

Rutgers University, Ph.D.

January 1997 - January 2001

Duquesne University, Master Of Science (M.S.)

January 1995 - January 1997

Birla Institute of Technology and Science, Pilani , B. Pharm.

January 1991 - January 1995

Frequently Asked Questions about Srini Ramanathan

What is Srini Ramanathan email address?

Srini Ramanathan's primary email address is ****************@roivant.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Srini Ramanathan work for?

Srini Ramanathan is a Chief Development Officer at Roivant Sciences.

Where Srini Ramanathan graduated from?

Srini Ramanathan holds a degree in Pharmaceutics from Rutgers University.

How can I directly contact Srini Ramanathan?

To contact Srini Ramanathan directly, you can use the email address ****************@roivant.com. Complete contact information is available upon registration with Muraena.

Is Srini Ramanathan an immigrant?

Yes, Srini Ramanathan is an immigrant and currently based in United States

Who is Srini Ramanathan?

Srini Ramanathan is an accomplished Chief Development Officer at Roivant Sciences, where he oversees R&D operations and the establishment of new therapeutic ventures. With extensive experience in biopharmaceutics and drug development, he has played a pivotal role in the approval of numerous drugs across various therapeutic areas, including oncology and HIV. Prior to his current role, he held senior leadership positions at Horizon and Abbvie, focusing on clinical development and strategic guidance in immunology. Srini's career is marked by his ability to engage with regulatory agencies globally, ensuring successful drug approvals. He holds a Ph.D. in Pharmaceutics from Rutgers University and has a strong academic foundation in pharmacy. His leadership experience spans multiple organizations, contributing to his reputation as a key figure in the biopharmaceutical industry. Beyond his professional achievements, he is known for his collaborative approach and commitment to advancing innovative therapies.

Srini`s contact details

mail

****************@roivant.com

****************@gilead.com

***********@horizonpharma.com

Colleagues

avatar
Paul Davis

Chief Communications Officer

avatar
Richard Pulik

Chief Financial Officer

avatar
Sudhir Penugonda

Executive Director

avatar
Stephanie Lee Griffin

VP, Special Projects, Office of CEO

avatar
Drew Fromkin

Chief Executive Officer

avatar
Shingai Majuru

Vice President, Head of CMC, Small Molecule Development

Eric Valeur

VP, Research

Keith Haan

Senior Vice President, Investments

avatar
Daniel Patterson

Vice President, Head of CMC, Biologics and Gene Therapies

View Contact details (it's free)
Request Profile Removal